InvestorsObserver
×
News Home

Can Altimmune Inc (ALT) Stock Rise to the Top of Healthcare Sector?

Monday, June 29, 2020 11:41 AM | InvestorsObserver Analysts

Mentioned in this article

Can Altimmune Inc (ALT) Stock Rise to the Top of Healthcare Sector?

Altimmune Inc (ALT) is around the top of the Healthcare sector according to InvestorsObserver.

ALT received an overall rating of 99, which means that it scores higher than 99% of stocks. Additionally, Altimmune Inc scored a 80 in the Healthcare sector, ranking it higher than 80% of stocks in that sector.

Overall Score - 99
ALT has an Overall Score of 99. Find out what this means to you and get the rest of the rankings on ALT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 99 means the stock is more attractive than 99 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.

Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Altimmune Inc Stock Today?

Altimmune Inc (ALT) stock is up 9.58% while the S&P 500 is flat 0% as of 11:38 AM on Monday, Jun 29. ALT has gained $1.01 from the previous closing price of $10.60 on volume of 3,115,563 shares. Over the past year the S&P 500 has risen 1.51% while ALT has gained 388.24%. ALT lost -$1.53 per share the over the last 12 months.

To screen for more stocks like ALT click here.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App